Novavax (NVAX)

Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. It works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. The company manages its business as one operating segment, an in-house early-stage R&D business to build a pipeline of high-value assets using its technology along with seeking to enter into partnerships to drive value creation for its assets.

的Novavax, Inc. Common Stock（NVAX）股票pre-market的价格今天是$9.44，自市场最后关闭以来，反映出-0.63%pre-market的变动。该公司市值为$15.34亿，日交易量为$9319.00股。前一交易日收盘价为 $9.50。

您准备好开始了吗？按照以下步骤操作，或阅读我们关于在Kraken上从10美元起购买Novavax股票的指南。